1-3 of 3
Melina Verso
Close
Sort by
Journal Articles

The effect of low-molecular-weight heparin in cancer patients: the mirror image of survival?

Sandro Barni, Erminio Bonizzoni, Melina Verso, Gualberto Gussoni, Fausto Petrelli, Tania Perrone, Giancarlo Agnelli
Journal: Blood
Blood (2014) 124 (1): 155–156.
https://doi.org/10.1182/blood-2014-03-561761
Published: 2014
Journal Articles

A Randomized Double-Blind Placebo-Controlled Study on Nadroparin for Prophylaxis of Thromboembolic Events in Cancer Patients Receiving Chemotherapy: The PROTECHT Study

Giancarlo Agnelli, M.D., Gualberto Gussoni, M.D., Carlo Bianchini, M.D., Melina Verso, M.D., Maurizio Tonato, M.D.
Journal: Blood
Blood (2008) 112 (11): 6.
https://doi.org/10.1182/blood.V112.11.6.6
Published: 2008
Journal Articles

Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies

Wael Saber, MD, MS, Teng Moua, MD, Eliot C. Williams, MD, PhD, Melina Verso, MD, Giancarlo Agnelli, MD, Stephen Couban, MD, Annie Young, RN, Marcello De Cicco, MD, Roberto Biffi, MD, Cornelis J. van Rooden, MD, Menno V. Huisman, MD, PhD, Daniele Fagnani, MD, Claudio Cimminiello, MD, Marco Moia, MD, Stephen P. Povoski, MD, Sharp Malak, MD, MPH, Agnes Y. Lee, MD, MSc, FRCPC
Journal: Blood
Blood (2008) 112 (11): 3814.
https://doi.org/10.1182/blood.V112.11.3814.3814
Published: 2008